News

New Zealand proposal for sole supply of Remicade in DHB hospitals

New Zealand proposal for sole supply of Remicade in DHB hospitals

31-10-2014

Following a Request for Tender for infliximab issued on September 2, 2014 (RFT), New Zealand’s Pharmaceutical…

Anti-Arthritics/RheumaticsAntibiotics and Infectious diseasesceftaroline fosamilFinancialJanssen-CilagJohnson & JohnsonNew ZealandPharmaceuticalPricingRemicade

Astellas details pipeline progress at R&D meeting

Astellas details pipeline progress at R&D meeting

11-07-2014

Japanese drug major Astellas Pharmaceuticals outlined its research framework at its R&D meeting held…

Anti-Arthritics/RheumaticsAntibiotics and Infectious diseasesAstellas PharmaBetmigaisavuconazoleJapanNephrology and HepatologyOncologyPharmaceuticalroxadustatXtandi

Briefs: Added use for Theravance's Vibativ; approval sought for ViiV dolutegravir; FDA accepts Pfizer sNDA for Xeljanz

23-06-2013

USA-based Theravance (Nasdaq: THRX) says that the US Food and Drug Administration has approved the firm's…

Anti-Arthritics/RheumaticsAnti-viralsAntibiotics and Infectious diseasesBiotechnologydolutegravirNorth AmericaPfizerPharmaceuticalRegulationTheravanceVibativViiV HealthcareXeljanz

South Africa awards 5.9 billion-rand antivirals tender; Panacela Russian contract

29-11-2012

The South African government has announced a 5.9 billion rand ($665 million) tender awarded to three…

Anti-Arthritics/RheumaticsAntibiotics and Infectious diseasesBiotechnologyCipla MedproCleveland BioLabsFinancialGeneralMylan LaboratoriesPanacela LabsRest of the WorldXenomycins

Pfizer to pay $2.3 Billion for fraudulent marketing, US Justice Dept reveals

03-09-2009

Global pharmaceutical behemoth Pfizer (which is in the process of acquiring fellow US drug major Wyeth…

Anti-Arthritics/RheumaticsAntibiotics and Infectious diseasesBextraGeodonLinezolidLyricaNeurologicalNorth AmericaPfizerPharmaceuticalPharmaciaPregabalinValdecoxibWyethZiprasidoneZyvox

Back to top